Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Singulair® (montelukast sodium) – New Boxed Warning
April 29, 2020 - The FDA approved a new Boxed Warning for brand and generic Singulair (montelukast) products regarding the risk of serious neuropsychiatric (NP) events.
